Amiodarone-associated Optic Neuropathy-A Clinical Criteria-based Diagnosis?

Neuro-ophthalmology
Katrin FaslerKlara Landau

Abstract

Amiodarone-associated optic neuropathy (AAON) is a controversial diagnosis with possible impact on vital cardiac therapy decisions. This retrospective case series aims for application of distinguishing features of AAON versus non-arteritic ischaemic optic neuropathy (NAION): Bilaterality, mode of onset, degree of optic nerve dysfunction, structure of uninvolved disc (unilateral cases), and systemic toxic effects. Applying these criteria to patients with disc swelling under amiodarone, the authors identified four unilateral disc swellings, one with NAION-typical features only and three with one or more NAION-atypical features. All three sequential and six bilateral cases showed one or more NAION-atypical features. The 12 cases highlight the persisting diagnostic dilemma arising from diversity of presentation, lack of plausible pathomechanism, and controversial existence of the entity itself.

References

Aug 1, 1987·Mayo Clinic Proceedings·L A FeinerF T Fraunfelder
Mar 1, 1987·Archives of Ophthalmology·J W Gittinger, G K Asdourian
Mar 11, 1998·Survey of Ophthalmology·M MäntyjärviK Ikäheimo
May 20, 1999·American Journal of Ophthalmology·D C MacalusoF T Fraunfelder
Aug 24, 1999·Pacing and Clinical Electrophysiology : PACE·A G SreihM A Marieb
Feb 10, 2000·Current Opinion in Cardiology·G V NaccarelliJ C Luck
Sep 23, 2000·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·M A SpeicherG A Chrousos
Oct 18, 2000·Japanese Journal of Ophthalmology·T EryilmazI Günalp
Nov 15, 2000·Klinische Monatsblätter für Augenheilkunde·D LeifertJ Gerling
Jul 20, 2002·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C A Uebermuth, E Gerke
Sep 5, 2002·American Journal of Ophthalmology·Nancy J NewmanUNKNOWN Ischemic Optic Neuropathy Decompression Trial Research Group
Mar 19, 2003·The British Journal of Ophthalmology·P K NagraR C Sergott
Oct 30, 2004·Seminars in Ophthalmology·David Chen, Thomas R Hedges
Jun 24, 2005·Klinische Monatsblätter für Augenheilkunde·G TurdumambetovaG I W Duncker
Sep 9, 2005·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Marjorie A Murphy, John F Murphy
May 10, 2006·Archives of Ophthalmology·Valerie PurvinFrancois-Xavier Borruat
Sep 13, 2006·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Roman ShinderRoger E Turbin
Apr 25, 2007·American Heart Journal·Joel S MindelUNKNOWN SCD-HeFT Investigators
Mar 1, 2008·Apoptosis : an International Journal on Programmed Cell Death·Takahisa YanoRyozo Oishi
Sep 2, 2008·American Heart Journal·Joel S Mindel
Mar 6, 2012·The American Journal of Medicine·Rod S PassmanJune M McKoy
Apr 13, 2012·Klinische Monatsblätter für Augenheilkunde·P P CiechanowskiV Sturm
Jul 16, 2014·Ophthalmology·Joel S Mindel
Dec 6, 2014·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Jonathan NicolasToine F H Bovee
Sep 24, 2015·Ophthalmology·Hui-Chen ChengAn-Guor Wang
Mar 30, 2017·Neuro-ophthalmology·An-Guor Wang, Hui-Chen Cheng

❮ Previous
Next ❯

Citations

Aug 12, 2020·Vestnik oftalmologii·O D OstroumovaL K Moshetova
Sep 29, 2019·La Revue de médecine interne·R ArcaniA Daumas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.